Pancreatic Cancer Research

ResearcherGuangxi Medical UniversityActive in the last 2 years

Tao Peng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6133-7078; OpenAlex author ID A5023103876. Sources: OpenAlex.

Their work

Papers
16 (first author 0, last author 15)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2017: 2 papers · 2018: 2 papers · 2019: 5 papers · 2020: 3 papers · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 16

  1. Pancreatic cancer mortality trends attributable to high fasting blood sugar over the period 1990-2019 and projections up to 2040. Last author DOI 10.3389/fendo.2024.1302436↗
  2. Comprehensive analysis of LILR family genes expression and tumour-infiltrating immune cells in early-stage pancreatic ductal adenocarcinoma. Last author DOI 10.1049/syb2.12058↗
  3. Prognostic value and potential molecular mechanism of the like-Sm gene family in early-stage pancreatic ductal adenocarcinoma. Last author DOI 10.21037/tcr-20-3056↗
  4. UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodene… Last author DOI 10.7150/jca.46084↗
  5. Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential… Last author DOI 10.1002/cam4.2699↗
  6. Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms. Last author DOI 10.1186/s12876-020-01560-0↗
  7. Genome-wide RNA-sequencing dataset reveals the prognostic value and potential molecular mechanisms of lncRNA in non-homologous end joining pathway 1 in early s… Last author DOI 10.7150/jca.39888↗
  8. Prognostic value of Kinesin-4 family genes mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy. Co-author DOI 10.1002/cam4.2524↗
  9. Evaluation of the diagnostic ability of laminin gene family for pancreatic ductal adenocarcinoma. Last author DOI 10.18632/aging.102007↗
  10. Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3389/fonc.2019.00511↗
  11. Cystatin F as a key family 2 cystatin subunit and prognostic biomarker for early‑stage pancreatic ductal adenocarcinoma. Last author DOI 10.3892/or.2019.7135↗
  12. Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after … Last author DOI 10.3892/or.2019.7277↗
  13. Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy. Last author DOI 10.2147/cmar.s168351↗
  14. Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy. Last author DOI 10.2147/cmar.s171293↗
  15. Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma. Last author DOI 10.2147/ott.s140221↗
  16. Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy. Last author DOI 10.2147/ott.s142557↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiwen Liao · 16 shared papers, 2017–2024 · strength 1.62
  2. Chengkun Yang · 13 shared papers, 2017–2023 · strength 1.22
  3. Xinping Ye · 9 shared papers, 2019–2023 · strength 0.94
  4. Xin Zhou · 8 shared papers, 2019–2024 · strength 0.90
  5. Quan‐Fa Han · 5 shared papers, 2018–2020 · strength 0.42
  6. Junqi Liu · 3 shared papers, 2019–2020 · strength 0.25
  7. Zijun Chen · 2 shared papers, 2020–2021 · strength 0.22
  8. Yongguang Wei · 1 shared paper, 2024 · strength 0.21
  9. Wei Qin · 1 shared paper, 2024 · strength 0.21
  10. Liming Shang · 2 shared papers, 2019–2020 · strength 0.18
  11. Qiongyuan Wu · 2 shared papers, 2019 · strength 0.17
  12. Qiang Gao · 1 shared paper, 2023 · strength 0.16
  13. Na Sun · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.